Overview

In vitro mRNA expression assays are essential tools for assessing the translational efficiency of therapeutic mRNA molecules delivered by lipid nanoparticles (LNPs).

These assays measure the amount of functional protein produced after transfection of mRNA into cultured cells, providing a direct readout of the mRNA's performance. Common readouts include reporter enzymes (e.g., luciferase) or fluorescent proteins (e.g., GFP), which allow rapid, high-throughput quantification. Alternatively, label-free quantification by LC/MS/MS can measure multiple protein antigens simultaneously, as demonstrated in recent mRNA vaccine evaluations.

By offering a standardized, cell-based platform, our service enables you to compare the expression efficiency of different LNP formulations, mRNA sequences, or chemical modifications in a controlled environment. The results help prioritize candidates for further development, reducing the need for costly animal studies at early stages.

Our integrated approach covers mRNA design, in vitro transcription (IVT) production, transfection optimization, and assay readout, all performed under consistent quality controls. This streamlined workflow accelerates the screening of ionizable lipids and other formulation components, ultimately supporting the development of safer and more effective mRNA therapeutics.

Key Features

Detection Methods

Select the detection method that best aligns with your experimental goals. Our service offers a range of proven modalities, from simple reporter assays to advanced mass spectrometry.

• Luciferase Reporter Assays: Quantify mRNA translation efficiency using firefly or Renilla luciferase. Luminescent signals are proportional to protein expression, enabling rapid, sensitive, and high-throughput quantification.
• Fluorescent Reporter Assays: Use GFP, mCherry, or other fluorescent proteins to monitor expression in live cells. Flow cytometry or plate-based fluorescence detection provides single-cell or population-level data.
• Secreted Protein Assays: Measure secreted reporter proteins (e.g., SEAP, Gaussian luciferase) or cytokines in culture supernatant. This non-lysis method allows time-course studies and preserves cells for downstream analysis.
• LC/MS/MS Multi-Antigen Quantification: Directly quantify multiple protein antigens from cell lysates or supernatants using liquid chromatography-tandem mass spectrometry. This label-free approach is ideal for vaccine antigen expression studies.
• Custom Detection (ELISA, Western Blot): For targets without ready-to-use reporters, we can develop an ELISA or Western blot assay to measure expression of your protein of interest. Assay development is tailored to your specific antibody reagents.

Workflow

Our streamlined workflow ensures consistent results from project initiation to final data report. Each step is optimized for reproducibility and scalability.

• Project Kickoff & Design: We discuss your experimental goals, select the appropriate mRNA construct (reporter gene or your sequence), choose the cell line, and define the assay conditions (e.g., transfection reagent, plate format, time points).
• mRNA Production & Quality Control: Your mRNA is synthesized via in vitro transcription (IVT) using plasmid or linearized DNA templates. Modified NTPs, cap analogs, and poly(A) tail lengths are optimized. QC includes RNA integrity, concentration, and purity.
• Cell Transfection & Incubation: The mRNA is transfected into the selected cell line using a validated transfection reagent (e.g., Lipofectamine MessengerMAX or proprietary LNPs). Cells are incubated for the predetermined expression time (typically 4–48 hours).
• Assay Readout & Data Analysis: Depending on the detection modality, we measure luminescence, fluorescence, secreted protein concentration, or protein mass spectrometry signals. Data are normalized to cell viability or transfection control and presented with statistical analysis.

Project Milestones

Each project follows a structured timeline. The exact duration depends on the complexity of the assay and the number of mRNA constructs. Typical milestones are outlined below.

• Assay Design & Approval: Finalize experimental design, select detection method, cell line, and controls. Obtain client approval.
• mRNA Synthesis & QC: Produce and quality-check the mRNA construct(s). This includes in vitro transcription, purification, and analytical testing.
• Transfection Optimization: Optimize transfection conditions (e.g., mRNA dose, lipid-to-mRNA ratio, cell density) for the chosen cell line and plate format.
• Expression Assay Execution: Carry out the full assay plate with replicates, controls, and standards. Perform the readout per the selected modality.
• Data Analysis & Report: Analyze raw data, generate graphs, and provide a comprehensive report including raw data, normalized results, and statistical summary.

Timelines are confirmed during project initiation based on scope and current capacity.

Quality Assurance

Every in vitro mRNA expression assay is performed using validated protocols and reagents. We include internal controls for transfection efficiency, assay linearity, and cell viability to ensure data integrity.

All mRNA constructs are verified by agarose gel electrophoresis, capillary electrophoresis, and spectrophotometry. Purity and integrity are documented and included in the final report.

Our scientists conduct each assay with appropriate technical replicates (typically triplicate) and plate layout randomization to minimize well-to-well variability. Data are reviewed by a senior scientist before release.

Why Choose Our In Vitro mRNA Expression Assay Service?

• End-to-End Service: We handle everything from mRNA design and synthesis to assay execution and data analysis, saving you time and reducing the risk of inconsistencies between different providers.
• Flexible Detection Options: Choose from a broad menu of detection methods (reporter genes, secreted proteins, LC/MS/MS) to match your specific research question and infrastructure.
• Proven Methodology: Our assays are based on established IVT and transfection protocols, and have been applied in published studies evaluating LNP formulations for mRNA vaccines and therapeutics.
• Scientific Expertise: Our team includes experienced molecular biologists and assay scientists who can advise on experimental design, including appropriate controls, time points, and data interpretation.
• Customizable to Your Needs: We can adapt the assay to your specific cell type, mRNA sequence, LNP formulation, or detection instrument. Custom modifications are discussed during the project kickoff.

Supported Cell Lines for Expression Assays

Our assays are validated across a diverse panel of commonly used cell lines. We can also work with your proprietary or primary cell types upon request.

• HEK293 / HEK293T: Human embryonic kidney cells widely used for transient expression due to high transfection efficiency and robust protein production. Suitable for initial screening of mRNA constructs.
• HeLa: Human cervical carcinoma cell line with good transfection efficiency and well-characterized biology. Often used for cancer-related mRNA expression studies.
• HepG2: Human hepatocyte-derived cell line commonly used for liver-targeted mRNA delivery studies. Provides a relevant model for hepatic LNP accumulation.
• A549: Human lung adenocarcinoma epithelial cells. Ideal for pulmonary delivery applications and for evaluating mRNA expression in respiratory cell models.
• Primary Cells (Custom): Primary human or animal cells (e.g., hepatocytes, fibroblasts, immune cells) can be used when a more physiologically relevant model is required. Assay conditions are optimized for each primary cell type.

Contact Us

Whether you are screening ionizable lipids, comparing LNP formulations, or validating the translational performance of your mRNA constructs, our scientific team is available to help you design the most appropriate assay strategy — from reporter selection and cell line choice to readout method and data analysis. Contact us today to learn more about our In Vitro mRNA Expression Assay service or discuss a tailored solution for your next project.